Translational Medicine

Translational Medicine
Open Access

ISSN: 2161-1025

+44 1223 790975

Maurizio Chiriva-Internati

Maurizio Chiriva-Internati

Department of Internal Medicine at the Division of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Dr. Chiriva-Internat is Kiromic’s Chief Executive Officer and Chief Scientific Officer. He is an Adjunct Associate Professor in the Department of Lymphoma & Multiple Myeloma at MD Anderson Cancer Center. For the past 20 years, Dr. Chiriva-Internati has investigated tumor antigens as therapeutic and diagnostic tools. His research has led to the identification of novel cancer-testis antigens for the development of immunotherapeutic strategies against solid and non-solid tumors.
Research Interest

Ovarian cancer,Immunotherapeutics.

Relevant Topics